TherapeuticsMD(DE:29TA)
€1.60+0.11 (+7.38%)
DE:29TA
TherapeuticsMD earnings date
€1.60
At close:+0.11 (+7.38%)
TherapeuticsMD (29TA) Q2 2021 Earnings Report
3 Followers
DE:29TA Q2 2021 EPS Results
- Actual EPS
- -EUR 4.97
- Consensus EPS
- -EUR 4.97
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -EUR 8.59
DE:29TA Q2 2021 Revenue Results
- Actual Revenue
- EUR 20.79M
- Expected Revenue
- EUR 19.99M
- Beat/Miss
- Beat by +EUR 801.79K
- YoY Revenue Growth
- +114.94%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/04/2021
- Time
- Before Open
- Conference Call
- Wednesday, August 4, 2021
DE:29TA Upcoming Earnings
TherapeuticsMD's next earnings date is estimated for November 17, 2026, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:29TA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 17, 2026 | 2026 (Q3) | ―- | 0.01 | ― | ― |
| Aug 11, 2026 | 2026 (Q2) | ―0.01 | 0.04 | -72.92% (-0.03) | |
| May 12, 2026 | 2026 (Q1) | ―0.01 | -0.05 | 114.29% (+0.06) | |
| Mar 30, 2026 | 2025 (Q4) | ―-0.05 | 0.02 | -345.45% (-0.07) | |
| Nov 12, 2025 | 2025 (Q3) | ―0.01 | -0.05 | 126.00% (+0.06) | |
| Aug 12, 2025 | 2025 (Q2) | ―0.04 | -0.08 | 153.33% (+0.12) | |
| May 13, 2025 | 2025 (Q1) | ―-0.05 | -0.06 | 20.00% (+0.01) | |
| Mar 27, 2025 | 2024 (Q4) | ―0.02 | -0.12 | 116.92% (+0.14) | |
| Nov 12, 2024 | 2024 (Q3) | ―-0.05 | -0.12 | 61.54% (+0.07) | |
| Aug 12, 2024 | 2024 (Q2) | ―-0.08 | -0.22 | 62.50% (+0.14) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
